Drugs / Glycocholic Acid
Glycocholic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01589523 | Feb 2006 → Jan 2019 | inborn disorder of bile acid synthesis, steroid inherited metabolic disorder | Children's Hospital Medical Center, Cincinnati | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycocholic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01589523 ↗ |
| Known as | Cholylglycine | ChEMBL registry synonym — accepted as the source's own label CHEMBL411070 ↗ |
| Known as | GCA | “with the conjugated bile acid, glycocholic acid (GCA).” PMID 25163551 ↗ Dec 2014 |
| Known as | Glycocholate | ChEMBL registry synonym — accepted as the source's own label CHEMBL411070 ↗ |
| Modality | Small molecule | — CHEMBL411070 ↗ |
| Route | Oral | “Subjects will be treated orally with conjugates of cholic acid” NCT01589523 ↗ |